印度|印度医学委员会：并非所有人都需要接种新冠疫苗疫苗|印度|新冠|委员会|医学

Entire population may not need to be vaccinated: ICMR
印度医学研究委员会：并非所有人都需要接种新冠疫苗

文章插图
NEW DELHI: It may not be necessary to vaccinate the entire population with Covid-19 vaccine as inoculating a critical mass of people might be enough to break the chain of viral transmission, Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava said on Tuesday.
新德里：印度医学研究委员会(ICMR)总干事巴尔拉姆·巴尔加瓦周二表示，可能没有必要为所有人接种新冠疫苗，为足够数量的人群接种后，或足以打破病毒传播链。
Dr Bhargava and health secretary Rajesh Bhushan also said a decision is yet to be taken on whether those who have been infected by the disease and recovered need to be administered the vaccine. While this might rationalise vaccine use, WHO literature said there is no need to measure anti-bodies before vaccination nor is there a need to find out if a person was infected.
巴尔加瓦博士和卫生部秘生拉杰什·布尚还说，尚未决定是否需要对已感染该病并康复的人接种疫苗。这可能使疫苗使用合理化，世卫组织指出，没有必要在接种疫苗之前检测抗体，也没有必要查明接种者是否感染了病毒。
“Our purpose is to break the chain of transmission. So, if we are able to vaccinate a critical mass of people and break the virus transmission then we may not have to vaccinate the entire population," Dr Bhargava said. Asked about a time-line for vaccinating the entire population, Bhushan said the go nment has not said the entire country will be inoculated with Covid-19 vaccine.
巴尔加瓦博士说：“我们的目的是打破传播链。因此，如果我们能够为足够数量的人群接种疫苗并阻断病毒传播，那就不必为所有人接种疫苗。”在被问及全国疫苗接种时间时，布尚表示，政府并未表示全国人口都要接种新冠疫苗。
“It's important that we discuss such scientific issues, based on factual information only,” Bhushan said. The go nment plans to vaccinate around 25-30 crore "priority" population including healthcare and front-line workers, elderly population and those with co-morbidities in around six months once the vaccine is rolled out and available for use.
布尚说:“讨论这样的科学问题是很重要的，我们只基于事实信息。”政府计划，一旦疫苗推出并可供使用，将在大约6个月内为大约2.5-3亿“优先”人口接种疫苗，其中包括一线医护工作者、老年人口和伴有并发症的人群。
The National Expert Group on Vaccine Administration for Covid-19 is also deliberating on whether people who have already recovered from the disease and carry antibodies need to be inoculated. Dr Bhargava said the matter is under discussion globally and though there is evidence that there may not be any adverse event if those who were infected are vaccinated, it would help the go nment spare limited doses in the initial phase of vaccination. There is strong evidence so far that those who have been infected are not likely to get Covid-19 again as long as they observe some basic precautions.
国家新冠肺炎疫苗管理专家组也在考虑是否对已痊愈且携带抗体的患者进行接种。巴尔加瓦博士说，全球都在讨论这个问题，尽管有证据表明，如果康复患者接种疫苗，可能不会发生不良反应，但这将有助于政府在疫苗接种的最初阶段留出有限的剂量。到目前为止，有有力的证据表明，康复患者只要遵守一些基本预防措施，就不太可能再次感染新冠病毒。
印度时报读者的评论：
Raghunandan Padhi
Icmr is 100?orrect...... Vaccination of only Politician , Bussinessman & Bollywood stars are enough...... No need to waste money on other remaining 3rd class citizens
ICMR说的没错，只要给政客、商人和宝莱坞明星接种就够了。没必要把钱浪费在其他三等公民身上
Nelson Dsouza
This is another opportunity for the politicians for a scam and pocket tax payers money like - 2g 3g 4g, coalgate, national herald, commonwealth games, etc etc. They will buy vaccines by the billions for Rs200 and show invoices of Rs2000 per vaccine. There is no hope for India with the highest co ption levels.
政客们又有机会诈骗纳税人的钱了。他们将以200卢比的价格购买疫苗，发票开2000卢比。附败程度最高的印度没有希望了。
Sanjoy Pandey
Dr. Bhargava is absolutely right. Moreover, those who have already developed anti-bodies need not be vaccinated.
巴尔加瓦博士说的绝对正确。此外，已经产生抗体的人不需要接种疫苗。
Sandeep
Vaccinate people with existing conditions first, then the elderly ( > 50) and then the rest if needed
先给确诊的人接种疫苗，然后是老年人(50岁以上)，如果需要，再给其他人接种